Self-assembling peptide as a potential carrier for hydrophobic anticancer drug ellipticine: Complexation, release and in vitro delivery

Advanced Functional Materials

Volumn 19, Issue 1, 2009, Pages 74-83

  Fung, Shan Yu ^a   Yang, Hong ^a   Bhola, Priya T ^b   Sadatmousavi, Parisa ^a   Muzar, Edward ^c   Liu, Mingyao ^d   Chen, P ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL MEMBRANES; CYTOLOGY; HYDROPHOBICITY; SCANNING ELECTRON MICROSCOPY; SUSPENSIONS (COMPONENTS);

ANTI CANCER AGENTS; ANTICANCER ACTIVITIES; AQUEOUS SOLUTIONS; CANCER CELL LINES; CRITICAL AGGREGATION CONCENTRATIONS; ELLIPTICINE; EQUILIBRATION TIMES; FUTURE DEVELOPMENTS; HYDROPHOBIC ANTICANCER DRUGS; HYDROPHOBIC COMPOUNDS; IN VITRO; IN-VIVO; MOLECULAR STATES; PEPTIDE CONCENTRATIONS; PHOSPHATIDYLCHOLINE VESICLES; PROTONATED; RELEASE KINETICS; SCANNING ELECTRON MICROGRAPHS; TRANSFER RATES;

AMINES;

EID: 58149375655     PISSN: 1616301X     EISSN: 16163028     Source Type: Journal    
DOI: 10.1002/adfm.200800860     Document Type: Article

References (44)

1. J. Kopecek, Eur.J. Pharm. Sci. 2003, 20, 1.
2. V. P. Torchilin, Curr. Drug Delivery 2005, 2, 319.
3. J. J. Schwartz, S. Zhang, Curr. Opin. Mol. Ther. 2000, 2, 162.
4. J. Hawiger, Curr. Opin. Chem. Biol. 1999, 3, 89.
5. O. H. Aina, T. C. Sroka, M.-L Chen, K. S. Lam, Biopolymers 2002, 66, 184.
6. F. X. Gu, R. Karnik, A. Z. Wang, F. Alexis, E. Levy-Nissenbaum, S. Hong, R. S. Langer, O. C. Farokhzad, Nanotoday 2007, 2, 14.
7. R. Langer, Nature 1998, 392, 5.
8. C. B. Carlson, P. Mowery, R. M. Owen, E. C. Dykhuizen, L. L. Kiessling, ACS Chem. Biol. 2007, 2, 119.
9. D. Derossi, G. Chassaing, A. Prochiantz, Trends Cell Biol. 1998, 8, 84.
10. M. Lindgren, M. Hallbrink, A. Prochiantz, U. Langel, Trends Pharmacol. Sci. 2000, 21, 99.
11. P. Lundberg, U. Langel, J. Mol. Recognit. 2003, 16, 227.
12. J. Temsamani, P. Vidal, Drug Discovery Today 2004, 9, 1012.
13. O. H. Aina, T. C. Sroka, M.-L. Chen, K. S. Lam, Biopolymers 2002, 66, 184.
14. J. Oehlke, B. Wiesner, M. Bienert, in Handbook of Cell-Penetrating Peptides, (Ed. U. Langel), CRC Press LLC, Boca Raton, FL 2002, pp. 71-92.
15. S. Y. Fung, Y. Hong, C. Keyes-Baig, P. Chen, in Molecular Interfacial Phenomena of Polymers and Biopolymers, (Ed: P. Chen), Woodhead Publishing Ltd., Cambridge, England 2005, pp. 421-474.
16. P. C. H. Hsieh, M. E. Davis, J. Gannon, C. MacGillivray, R. T. Lee, J. Clin. Invest. 2006, 116, 237.
17. M. E. Davis, P. C. H. Hsieh, T. Takahashi, Q. Song, S. Zhang, R. D. Kamm, A. J. Grodzinsky, P. Anversa, R. T. Lee, Proc. Natl. Acad. Sci. USA2006, 103, 8155.
18. T. C. Holmes, S. de Lacalle, X. Su, G. Liu, A. Rich, S. Zhang, Proc. Natl. Acad. Sci. USA 2000, 97, 6728.
19. S. Zhang, T. Holmes, C. Lockshin, A. Rich, Proc. Natl. Acad. Sci. USA 1993, 90, 3334.
20. S. Zhang, T. Holmes, C. M. DiPersio, R. O. Hynes, X. Su, A. Rich, Biomaterials 1995, 16, 1385.
21. C. Keyes-Baig, J. Duhamel, S. Y. Fung, J. Bezaire, P. Chen, J. Am. Chem. Soc. 2004, 126, 7522.
22. S. Y. Fung, H. Yang, P. Chen, Colloids Surf. B 2007, 55, 200.
23. S. Y. Fung, J. Duhamel, P. Chen, J. Phys. Chem. A 2006, 110, 11446.
24. J. Liu, Y. Xiao, C. Allen, J. Pharm. Sci. 2004, 93, 132.
25. J. Duhamel, in Molecular Interfacial Phenomena of Polymers and Biopolymers, (Ed: P. Chen), Woodhead Publishing Ltd., Cambridge, England 2005, pp. 214-248.
26. N. C. Garbett, D. E. Graves, Curr. Med. Chem.: Anti-Cancer Agents 2004, 4, 149.
27. A. Clarysse, A. Brugarolas, P. Siegenthaler, R. Abele, F. Cavalli, R. de Jager, G. Renard, M. Rozencweig, H. H. Hansen, Eur. J. Cancer Clin. Oncol. 1984, 20, 243.
28. M. Sbai, S. Ait Lyazidi, D. A. Lerner, B. del Castillo, M. A. Martin, J. Pharm. Biomed. Anal. 1996, 14, 959.
29. J. M. El Hage Chahine, J.-P. Bertigny, M.-A. Schwaller, J. Chem. Soc. Perkin Trans. 2 1989, 629.
30. H. Yang, S. Y. Fung, M. D. Pritzker, P. Chen, J. Am. Chem. Soc. 2007, 129, 12200.
31. H. Yang, S. Y. Fung, M. D. Pritzker, P. Chen, PLoS One 2007, 2, e1325.
32. S. Y. Fung, C. Keyes, C. Duhamel, P. Chen, Biophys J. 2003, 85, 537.
33. M. Sainsbury, in The Chemistry of Antitumour Agents, (Ed: D. E. V. Wilman), Chapman and Hall, New York, NY 1990, pp. 411-435.
34. J. L. S. Au, S. H. Jang, M. G. Wientjes, J. Controlled Release 2002, 78, 81.
35. C. Cortez, E. Tomaskovic-Crook, A. P. R. Johnston, A. M. Scott, E. C. Nice, J. K. Heath, F. Caruso, ACS Nano 2007, 1, 93.
36. G. Kong, R. D. Braun, M. W. Dewhirst, Cancer Res. 2000, 60, 4440.
37. W. Zauner, N. A. Farrow, A. M. R. Haines, J. Controlled Release 2001, 71, 39.
38. K. Y. Win, S.-S. Feng, Biomaterials 2005, 26, 2713.
39. I. Brigger, C. Dubernet, P. Couvreur, Adv. Drug Delivery Rev. 2002, 54, 631.
40. K. Greish, J. Drug Targeting 2007, 15, 457.
41. H. Maeda, T. Sawa, T. Konno, J. Controlled Release 2001, 74, 47.
42. X. Li, D. J. Hirsh, D. Cabral-Lilly, A. Zirkel, S. M. Gruner, A. S. Jano, W. R. Perkins, Biochim. Biophys. Acta 1998, 1415, 23.
43. R. Garcia-Carbonero, J. G. Supko, Clin. Cancer Res. 2002, 8, 641.
44. A. Hatefi, B. Amsden, Pharm. Res. 2002, 19, 1389.